Oro Muscles files Form D for $2 million equity offering
The Melbourne, Florida biotechnology company reported $350,000 sold so far from one investor, with a first sale date of July 17, 2026.
Oro Muscles, Inc., a Delaware corporation formed in 2023 and based in Melbourne, Florida, filed a Form D notice with the Securities and Exchange Commission disclosing an exempt securities offering. The company claimed an exemption under Rule 506(b).1
The filing lists Oro Muscles, Inc. as the issuer, a corporation.1 The company classified its industry as biotechnology within the health care sector.1
The notice marks a new filing, with a date of first sale listed as July 17, 2026.1 The company indicated it does not intend the offering to last more than one year.1 The securities offered include equity as well as an option, warrant, or other right to acquire another security.1
The filing states that the offering is not tied to a merger, acquisition, or exchange offer transaction.
On the financial terms, the total offering amount is listed as $2,000,000, with $350,000 already sold and $1,650,000 remaining to be sold.1 The minimum investment accepted from any outside investor is listed as $0.1 The filing reports a total of one investor who has already invested in the offering.1
The company reported $0 in sales commissions and $0 in finders' fees.1 It estimated that $400,000 of gross proceeds would go toward payments to executive officers, directors, or promoters named in the filing.1
Related persons named in the filing include Tanya Colonna, listed as an executive officer, director, and promoter; Travis Stallings, listed as an executive officer; and Hobey Tam, listed as an executive officer and director, all sharing an address at 2412 Irwin St, Melbourne, Florida.1
The notice was signed by Travis Stallings, identified as Secretary and Chief Operating Officer, dated July 31, 2026.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.